OBJECTIVE: Guidelines for oral anticoagulation after deep venous thrombosis (DVT) or pulmonary embolism (PE) have recommended that patients be anticoagulated for at least 3 months after hospital discharge. We sought to determine whether this recommendation was being followed and what patient ...
The authors conducted a review of the literature to establish reasonable practical guidelines for the management of complications in patients who have undergone recent spinal surgery and who require Level 1 anticoagulation therapy.A MEDLINE (PubMed) literature search was performed using the key words "...
The mainstay of treatment for DVT isanticoagulation therapy. However, optimal anticoagulation strategies for cancer patients with isolated distal DVT are not currently established. ONCO DVT was the first randomized trial to compare two different treatment durations of the oral factor Xa inhibitor edoxaban...
Objectives & Background There is currently little evidence defining the clinical importance of detecting and treating isolated distal deep vein thrombosis (IDDVT). Contemporary international guidelines vary regarding diagnostic and therapeutic advice. The potential benefits of anticoagulation remain poorly defin...
The Seventh American College of Chest Physicians (ACCP) Conference on Antithrombotic and Thrombolytic Therapy provides guidelines for outpatient management... ALD Breuil,EM Umland - 《American Family Physician》 被引量: 129发表: 2007年 A model for perioperative outpatient management of anticoagulation in...
As a consequence, practice guidelines base their recommendations on available evidence from retrospective cohorts studies and extrapolation from interventional studies of deep vein thrombosis (DVT) and acute pulmonary embolism (PE).4-6 The latter makes sense considering some shared pathophysiological ...
The mainstay of medical treatment fordeep venous thrombosis(DVT) isanticoagulant therapy. Most patients (approximately90%) treated with anticoagulant therapy show no immediate demonstrable physical sequelae of DVT.This form of treatmentis noninvasive and is associated with a low risk for complications,...
those with levels <0.1 IU/mL had an increased risk of developing DVT [208]. However, this study also found that increased body weight partially correlated with low anti-Xa activity. Nevertheless, 12-h/trough anti-Xa monitoring of LMWH for VTE thromboprophylaxis in high risk critically ill...
(ACCP) consensus guidelines updated treatment recommendations for the first episode of idiopathic VTE [2] by modifying their previous recommendation of 6–12 months treatment [5], to “at least three months.” This change reflects the uncertainty surrounding the appropriate duration for anticoagulation...
Additionally, during the coronavirus disease 2019 pandemic, centers monitored anti-Xa levels for VTE prophylaxis to individualize therapy owing to the high rates of DVT and PE seen in this patient population.18 The currently established goal peak anti-Xa level is 0.2–0.5 IU/mL for enoxaparin 40...